Landscapes / Companies
Kyntra Bio not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 4 in all
Trials
2 active
27 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved in EU, Japan, China | Sep 2030Phase 3 trial completes | |||
| Next date | Sep 2030 · Phase 3 trial completes | ||||
| Also tested for | Myelodysplastic Syndromes | ||||
| Open drug page | |||||
— |
Phase 2 | 31 Mar 2028Phase 2 trial completes | |||
| Next date | 31 Mar 2028 · Phase 2 trial completes | ||||
| Also tested for | Metastatic Castration-Resistant Prostate Cancer | ||||
| Open drug page | |||||
About
- No active trial
- Iron, Pamrevlumab
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021